Table 14:
Budget Impact of Adopting Flash Glucose Monitoring, Reference Case
| Variable | Budget Impact, $a | ||||
|---|---|---|---|---|---|
| Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
| Type 1 diabetes | |||||
| SMBG (current scenario) | 7,640,943 | 10,528,830 | 13,588,063 | 16,815,072 | 20,211,641 |
| Flash (new scenario) | 10,542,979 | 14,527,689 | 18,748,821 | 23,201,450 | 27,888,039 |
| Net budget impact of T1D | 2,902,036 | 3,998,858 | 5,160,758 | 6,386,378 | 7,676,398 |
| Type 2 diabetes | |||||
| SMBG (current scenario) | 10,933,991 | 15,068,894 | 19,447,726 | 24,066,917 | 28,926,469 |
| Flash (new scenario) | 22,630,095 | 31,188,108 | 40,250,982 | 49,811,329 | 59,869,149 |
| Net budget impact of T2D | 11,696,104 | 16,119,214 | 20,803,256 | 25,744,411 | 30,942,680 |
| Net budget impact of T1D and T2D | 14,598,140 | 20,118,072 | 25,964,014 | 32,130,789 | 38,619,078 |
Abbreviations: SMBG, self-monitoring of blood glucose; T1D, type 1 diabetes; T2D, type 2 diabetes.
a
Numbers may be inexact because of rounding.